Alternative Splicing in the Hippo Pathway—Implications for Disease and Potential Therapeutic Targets

Alternative splicing is a well-studied gene regulatory mechanism that produces biological diversity by allowing the production of multiple protein isoforms from a single gene. An involvement of alternative splicing in the key biological signalling Hippo pathway is emerging and offers new therapeutic...

Full description

Bibliographic Details
Main Authors: Sean Porazinski, Michael Ladomery
Format: Article
Language:English
Published: MDPI AG 2018-03-01
Series:Genes
Subjects:
Online Access:http://www.mdpi.com/2073-4425/9/3/161
id doaj-c75de1b1b17c4d2fa4fdc22869762929
record_format Article
spelling doaj-c75de1b1b17c4d2fa4fdc228697629292020-11-24T21:04:47ZengMDPI AGGenes2073-44252018-03-019316110.3390/genes9030161genes9030161Alternative Splicing in the Hippo Pathway—Implications for Disease and Potential Therapeutic TargetsSean Porazinski0Michael Ladomery1Faculty of Health and Applied Sciences, University of the West of England, Frenchay Campus, Bristol BS16 1QY, UKFaculty of Health and Applied Sciences, University of the West of England, Frenchay Campus, Bristol BS16 1QY, UKAlternative splicing is a well-studied gene regulatory mechanism that produces biological diversity by allowing the production of multiple protein isoforms from a single gene. An involvement of alternative splicing in the key biological signalling Hippo pathway is emerging and offers new therapeutic avenues. This review discusses examples of alternative splicing in the Hippo pathway, how deregulation of these processes may contribute to disease and whether these processes offer new potential therapeutic targets.http://www.mdpi.com/2073-4425/9/3/161Hippo pathwayalternative splicingyes-associated proteinsplice-switching oligonucleotidesgene therapy
collection DOAJ
language English
format Article
sources DOAJ
author Sean Porazinski
Michael Ladomery
spellingShingle Sean Porazinski
Michael Ladomery
Alternative Splicing in the Hippo Pathway—Implications for Disease and Potential Therapeutic Targets
Genes
Hippo pathway
alternative splicing
yes-associated protein
splice-switching oligonucleotides
gene therapy
author_facet Sean Porazinski
Michael Ladomery
author_sort Sean Porazinski
title Alternative Splicing in the Hippo Pathway—Implications for Disease and Potential Therapeutic Targets
title_short Alternative Splicing in the Hippo Pathway—Implications for Disease and Potential Therapeutic Targets
title_full Alternative Splicing in the Hippo Pathway—Implications for Disease and Potential Therapeutic Targets
title_fullStr Alternative Splicing in the Hippo Pathway—Implications for Disease and Potential Therapeutic Targets
title_full_unstemmed Alternative Splicing in the Hippo Pathway—Implications for Disease and Potential Therapeutic Targets
title_sort alternative splicing in the hippo pathway—implications for disease and potential therapeutic targets
publisher MDPI AG
series Genes
issn 2073-4425
publishDate 2018-03-01
description Alternative splicing is a well-studied gene regulatory mechanism that produces biological diversity by allowing the production of multiple protein isoforms from a single gene. An involvement of alternative splicing in the key biological signalling Hippo pathway is emerging and offers new therapeutic avenues. This review discusses examples of alternative splicing in the Hippo pathway, how deregulation of these processes may contribute to disease and whether these processes offer new potential therapeutic targets.
topic Hippo pathway
alternative splicing
yes-associated protein
splice-switching oligonucleotides
gene therapy
url http://www.mdpi.com/2073-4425/9/3/161
work_keys_str_mv AT seanporazinski alternativesplicinginthehippopathwayimplicationsfordiseaseandpotentialtherapeutictargets
AT michaelladomery alternativesplicinginthehippopathwayimplicationsfordiseaseandpotentialtherapeutictargets
_version_ 1716769757934387200